stars 1 stars 2 stars 3

Our flagship stabilization solutions — TheraPHIX™, vivoPHIX™, genoPHIX™, virusPHIX™ and virusPHIX-P9™ — are designed for a wide range of applications within life sciences and therapeutics. vivoPHIX™ leverages advanced molecular stabilization technology to ensure sample integrity during tissue fixation, dissociation, and single-cell workflows, including scRNA-seq and CITE-seq. virusPHIX™ facilitates virus inactivation and secure transport, preserving molecular fidelity for improved diagnostic accuracy and high-quality data generation. For mRNA-LNP vaccine and therapeutic thermostabilization TheraPHIX™ improves stability and potency in the form an ambient stable injectable liquid formulation.

RNAssist Questions

The RNAssist annual revenue was $3 million in 2026.

1 people are employed at RNAssist.

RNAssist is based in Cambridge, England.

The NAICS codes for RNAssist are [5417, 54171, 54, 541713, 541].

The SIC codes for RNAssist are [87, 873].

Top RNAssist Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users